vs
Dayforce（DAY）とPrestige Consumer Healthcare Inc.（PBH）の財務データ比較。上の社名をクリックして会社を切り替えられます
Dayforceの直近四半期売上が大きい（$481.6M vs $283.4M、Prestige Consumer Healthcare Inc.の約1.7倍）。Prestige Consumer Healthcare Inc.の純利益率が高く（16.5% vs -40.9%、差は57.3%）。Dayforceの前年同期比売上増加率が高い（9.5% vs -2.4%）。過去8四半期でDayforceの売上複合成長率が高い（9.8% vs 1.2%）
Dayforce（旧社名Ceridian）は米国に本拠を置く人事ソフトウェア・サービス企業です。給与計算、勤怠管理、人材管理など多様な業務シーンに対応したHR SaaS製品や専門サービスを提供し、企業の人事業務の効率化を支援しています。
プレステージ・コンシューマー・ヘルスケア社はアメリカの企業で、一般用医薬品のヘルスケア製品および家庭用洗浄製品の販売・流通を手がけています。1996年にMedtech Products社、Prestige Brands International社、Spic and Span社の合併により設立され、本社はニューヨーク州タリータウン、バージニア州リンチバーグに製造工場を構えています。
DAY vs PBH — 直接比較
損益計算書 — Q3 FY2025 vs Q3 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $481.6M | $283.4M |
| 純利益 | $-196.8M | $46.7M |
| 粗利率 | — | 55.5% |
| 営業利益率 | 6.3% | 29.1% |
| 純利益率 | -40.9% | 16.5% |
| 売上前年比 | 9.5% | -2.4% |
| 純利益前年比 | -9940.0% | -23.5% |
| EPS（希薄化後） | $-1.23 | $0.97 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | — | $283.4M | ||
| Q3 25 | $481.6M | $274.1M | ||
| Q2 25 | $464.7M | $249.5M | ||
| Q1 25 | $481.8M | $296.5M | ||
| Q4 24 | $465.2M | $290.3M | ||
| Q3 24 | $440.0M | $283.8M | ||
| Q2 24 | $423.3M | $267.1M | ||
| Q1 24 | $431.5M | $277.0M |
| Q4 25 | — | $46.7M | ||
| Q3 25 | $-196.8M | $42.2M | ||
| Q2 25 | $21.3M | $47.5M | ||
| Q1 25 | $14.9M | $50.1M | ||
| Q4 24 | $10.8M | $61.0M | ||
| Q3 24 | $2.0M | $54.4M | ||
| Q2 24 | $-1.8M | $49.1M | ||
| Q1 24 | $7.1M | $49.5M |
| Q4 25 | — | 55.5% | ||
| Q3 25 | — | 55.3% | ||
| Q2 25 | — | 56.2% | ||
| Q1 25 | — | 57.3% | ||
| Q4 24 | 47.0% | 55.5% | ||
| Q3 24 | 45.8% | 55.5% | ||
| Q2 24 | 44.1% | 54.7% | ||
| Q1 24 | 47.6% | 54.8% |
| Q4 25 | — | 29.1% | ||
| Q3 25 | 6.3% | 29.1% | ||
| Q2 25 | 9.1% | 28.8% | ||
| Q1 25 | 6.4% | 29.8% | ||
| Q4 24 | 6.1% | 31.7% | ||
| Q3 24 | 4.7% | 29.7% | ||
| Q2 24 | 3.3% | 27.0% | ||
| Q1 24 | 9.4% | 29.7% |
| Q4 25 | — | 16.5% | ||
| Q3 25 | -40.9% | 15.4% | ||
| Q2 25 | 4.6% | 19.0% | ||
| Q1 25 | 3.1% | 16.9% | ||
| Q4 24 | 2.3% | 21.0% | ||
| Q3 24 | 0.5% | 19.2% | ||
| Q2 24 | -0.4% | 18.4% | ||
| Q1 24 | 1.6% | 17.9% |
| Q4 25 | — | $0.97 | ||
| Q3 25 | $-1.23 | $0.86 | ||
| Q2 25 | $0.13 | $0.95 | ||
| Q1 25 | $0.09 | $1.00 | ||
| Q4 24 | $0.07 | $1.22 | ||
| Q3 24 | $0.01 | $1.09 | ||
| Q2 24 | $-0.01 | $0.98 | ||
| Q1 24 | $0.04 | $0.98 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $627.6M | $62.4M |
| 総負債低いほど良い | $631.1M | $1.0B |
| 株主資本純資産 | $2.7B | $1.8B |
| 総資産 | $8.7B | $3.5B |
| 負債/資本比率低いほどレバレッジが低い | 0.23× | 0.56× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | — | $62.4M | ||
| Q3 25 | $627.6M | $119.1M | ||
| Q2 25 | $625.2M | $139.5M | ||
| Q1 25 | $557.3M | $97.9M | ||
| Q4 24 | $579.7M | $50.9M | ||
| Q3 24 | $494.1M | $51.5M | ||
| Q2 24 | $465.4M | $34.3M | ||
| Q1 24 | $392.5M | $46.5M |
| Q4 25 | — | $1.0B | ||
| Q3 25 | $631.1M | $993.1M | ||
| Q2 25 | $631.8M | $992.7M | ||
| Q1 25 | $632.4M | $992.4M | ||
| Q4 24 | $1.2B | $992.0M | ||
| Q3 24 | $1.2B | $1.1B | ||
| Q2 24 | $1.2B | $1.1B | ||
| Q1 24 | $1.2B | $1.1B |
| Q4 25 | — | $1.8B | ||
| Q3 25 | $2.7B | $1.8B | ||
| Q2 25 | $2.7B | $1.9B | ||
| Q1 25 | $2.6B | $1.8B | ||
| Q4 24 | $2.5B | $1.8B | ||
| Q3 24 | $2.6B | $1.7B | ||
| Q2 24 | $2.5B | $1.7B | ||
| Q1 24 | $2.4B | $1.7B |
| Q4 25 | — | $3.5B | ||
| Q3 25 | $8.7B | $3.4B | ||
| Q2 25 | $8.5B | $3.4B | ||
| Q1 25 | $9.5B | $3.4B | ||
| Q4 24 | $9.1B | $3.3B | ||
| Q3 24 | $8.1B | $3.3B | ||
| Q2 24 | $9.0B | $3.3B | ||
| Q1 24 | $10.8B | $3.3B |
| Q4 25 | — | 0.56× | ||
| Q3 25 | 0.23× | 0.54× | ||
| Q2 25 | 0.23× | 0.54× | ||
| Q1 25 | 0.24× | 0.54× | ||
| Q4 24 | 0.47× | 0.55× | ||
| Q3 24 | 0.47× | 0.61× | ||
| Q2 24 | 0.49× | 0.65× | ||
| Q1 24 | 0.50× | 0.68× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $31.2M | $78.3M |
| フリーキャッシュフロー営業CF - 設備投資 | — | $75.3M |
| FCFマージンFCF / 売上 | — | 26.6% |
| 設備投資強度設備投資 / 売上 | — | 1.1% |
| キャッシュ転換率営業CF / 純利益 | — | 1.68× |
| 直近12ヶ月FCF直近4四半期 | — | $267.2M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | — | $78.3M | ||
| Q3 25 | $31.2M | $57.5M | ||
| Q2 25 | $112.7M | $79.0M | ||
| Q1 25 | $49.6M | $61.8M | ||
| Q4 24 | $81.0M | $65.1M | ||
| Q3 24 | $91.8M | $69.8M | ||
| Q2 24 | $99.2M | $54.8M | ||
| Q1 24 | $9.1M | $66.9M |
| Q4 25 | — | $75.3M | ||
| Q3 25 | — | $55.4M | ||
| Q2 25 | — | $78.2M | ||
| Q1 25 | — | $58.4M | ||
| Q4 24 | — | $63.5M | ||
| Q3 24 | — | $67.8M | ||
| Q2 24 | — | $53.6M | ||
| Q1 24 | — | $63.8M |
| Q4 25 | — | 26.6% | ||
| Q3 25 | — | 20.2% | ||
| Q2 25 | — | 31.3% | ||
| Q1 25 | — | 19.7% | ||
| Q4 24 | — | 21.9% | ||
| Q3 24 | — | 23.9% | ||
| Q2 24 | — | 20.1% | ||
| Q1 24 | — | 23.0% |
| Q4 25 | — | 1.1% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 1.2% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 0.4% | ||
| Q1 24 | — | 1.1% |
| Q4 25 | — | 1.68× | ||
| Q3 25 | — | 1.36× | ||
| Q2 25 | 5.29× | 1.66× | ||
| Q1 25 | 3.33× | 1.23× | ||
| Q4 24 | 7.50× | 1.07× | ||
| Q3 24 | 45.90× | 1.28× | ||
| Q2 24 | — | 1.12× | ||
| Q1 24 | 1.28× | 1.35× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
DAY
| Dayforce Recurring | $333.0M | 69% |
| Cloud And Bureau Professional Services And Other | $78.5M | 16% |
| Float | $42.2M | 9% |
| Powerpay Recurring | $19.7M | 4% |
| Other Recurring | $8.2M | 2% |
PBH
| Womens Health | $51.8M | 18% |
| International OTC Healthcare | $47.7M | 17% |
| Gastrointestinal | $44.2M | 16% |
| Eye And Ear Care | $35.2M | 12% |
| Dermatologicals | $27.6M | 10% |
| Analgesics | $26.7M | 9% |
| Oral Care | $23.5M | 8% |
| Cough And Cold | $23.0M | 8% |
| Other Otc | $3.6M | 1% |
